Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05682313
Other study ID # MD-53-2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 7, 2021
Est. completion date October 24, 2022

Study information

Verified date December 2022
Source Kasr El Aini Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic allograft nephropathy is one of dreaded complication of kidney transplant. It is one of the major determinants of long term graft survival. There are a number of factors that can contribute to chronic allograft nephropathy including chronic use of calcineurin inhibitors. Renal biopsy is the investigation of choice to detect chronic renal allograft nephropathy. renal biopsy has a number of complications . This includes infection and bleeding. The non invasive renal sono-elastography (strain and Shear Wave Imaging) technique has shown very good yield of detecting and scoring fibrosis. In this study our aim is to determine the sensitivity and specificity of ( strain sono-elastography) in the detection and classifying of chronic allograft nephropathy as compared to transcutaneous renal biops


Description:

Chronic allograft nephropathy is one of dreaded complication of kidney transplant. It is one of the major determinants of long term graft survival. There are a number of factors that can contribute to chronic allograft nephropathy including chronic use of calcineurin inhibitors. Renal biopsy is the investigation of choice to detect chronic renal allograft nephropathy. renal biopsy has a number of complications . This includes infection and bleeding. The non invasive renal sono-elastography (strain and Shear Wave Imaging) technique has shown very good yield of detecting and scoring fibrosis. In this study our aim is to determine the sensitivity and specificity of ( strain sono-elastography) in the detection and classifying of chronic allograft nephropathy as compared to transcutaneous renal biopsy


Recruitment information / eligibility

Status Completed
Enrollment 188
Est. completion date October 24, 2022
Est. primary completion date July 13, 2022
Accepts healthy volunteers No
Gender All
Age group 14 Years to 55 Years
Eligibility Inclusion Criteria: Renal transplant patients of more than 2 years duration, Chronic allograft nephropathy proved by renal biopsy done within 1 month from the date of the strain elastography, Body mass index less than 30 kg/m2, Skin allograft distance of less than 3.5 cm, Parenchyma thickness of more than 1 cm and no fluid accumulation around the allograft. Exclusion Criteria: Body mass index more than 30 kg/m2, Skin allograft distance more than 3.5 cm, Parenchymal thickness less than 1 cm, Presence of any fluid collection around the allograft, GFR less than 15 ml/min, Graft stones or backpressure and less than 14 years old or more than 55 years old.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Elastography arm
Renal ultrasound elastography to detect and classify the degree of fibrosis

Locations

Country Name City State
Egypt Cairo university hospitals Cairo

Sponsors (1)

Lead Sponsor Collaborator
Kasr El Aini Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Grade of fibrosis degree of fibrosis obtained by elastography At the time of recruitment
See also
  Status Clinical Trial Phase
Recruiting NCT01346397 - Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation N/A
Recruiting NCT00999258 - Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients Phase 4
Completed NCT01265615 - Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients Phase 4
Recruiting NCT00541814 - Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function Phase 4
Not yet recruiting NCT00659620 - Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy Phase 1/Phase 2
Completed NCT01056835 - Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy Phase 3
Completed NCT00975000 - Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Phase 3
Terminated NCT00568477 - Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation Phase 2
Completed NCT00007787 - Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants N/A
Completed NCT00005010 - Prevention of Kidney Transplant Rejection Phase 3